Lexpos News

Drug alert number: EL(22)A/42 Date issued: 10 October 2022 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion – Hameln pharma ltd – PL 25215/0026 Batch Number Expiry Date Pack Size First Distributed 210505 03/2024 10 x 3 ml [...]

The post MHRA Class 2 Medicines Recall: Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion appeared first on PSNC Website.

NHS England (NHSE) has published guidance on the 2022/23 Pharmacy Quality Scheme (PQS). The guidance document provides information on how community pharmacy contractors can meet the gateway criteria and domain requirements. Contractors are encouraged to read the NHSE guidance in order to understand the PQS requirements. Read the NHSE PQS 2022/23 guidance Further information on [...]

The post PQS: NHS England 2022/23 guidance published appeared first on PSNC Website.

Following its meeting on the 21st of September 2022, the Community Pharmacy IT Group (CP ITG) has published its quarterly Pharmacy IT roundup for Autumn 2022. The roundup includes updates on: Current prioritisation by NHS IT policy makers and the CP ITG The progress made concerning pharmacy IT standards Upcoming events which pharmacy team members [...]

The post Update on pharmacy IT workstreams published appeared first on PSNC Website.

Community pharmacy contractors are reminded that if they intend to meet the Respiratory domain of the Pharmacy Quality Scheme (PQS) 2022/23, they must start working towards the following quality criteria from today (10th October 2022):  Inhaler waste management;  Use of a spacer in patients aged 5-15 years; and  Personalised asthma action plans.   Most pharmacy teams will be [...]

The post PQS 2022/23 starts today – are you ready to start working towards the Respiratory domain? appeared first on PSNC Website.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Combisal®125mcg/25mcg inhalers is now available to meet normal demand. As a result the Serious Shortage Protocol, SSP034 Combisal®125mcg/25mcg inhalers expires at 23.59pm on Friday 7 October 2022. After this date, any prescriptions for Combisal®125mcg/25mcg inhalers must be dispensed in accordance with [...]

The post Contractor Notice: Expiry of SSP034 Combisal®125mcg/25mcg inhalers appeared first on PSNC Website.